EUVIMEDEUVIMED entdecken
Crossref

Treatment of Stomal Incontinence with Coaptite Injections in Continent Cutaneous Urinary Diversions

Josh Ku, Chirag Doshi, Michael Basin, Anosh Dadabhoy, Adam Peña, Leilei Xia, David Ginsberg, Hooman Djaladat, Siamak Daneshmand

Journal of Endourology · 21.11.2026

DOI: 10.1177/08927790261508366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endourology, online erschienen am 21.11.2026. Verfasst von Josh Ku und 8 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Catheterizable stomal incontinence in continent cutaneous urinary diversions (CCUDs) is a well-documented complication. There are limited reports of using urethral bulking agents in treating stomal incontinence after CCUD. We discuss our experience using Coaptite, an U.S. Food and Drug Administration (FDA)-approved urethral bulking agent, to treat incontinence following CCUD.

Methods

We reviewed 16 patients with CCUDs who underwent Coaptite injections between 2012 and 2024. This included ten right colon reservoirs, four native bladders with augmentation plus catheterizable channel, and two revised neobladders who underwent urethrectomy and addition of catheterizable channel. Coaptite was injected near the efferent limb-reservoir junction. Outcomes were categorized as full continence (FC), improved continence (IC), no improved continence (NIC), or worsened continence (WC).

Results

Of the 16 patients, 13 (81%) demonstrated positive outcomes in response to Coaptite injections, with 8 (50%) achieving FC, and 5 (31%) IC, with a mean of 2.25 injections per patient. No patients had WC. Among the patients with right colon reservoirs, 9 of 10 had positive outcomes (8 FC, 1 IC). Among those with native bladders or neobladders, 4 of 6 achieved IC, and none achieved FC. By channel type, 7 of the 9 patients with appendiceal channels had positive outcomes (5 FC, 2 IC), whereas 6 of the 7 patients with ileal channels achieved positive outcomes (3 FC, 3 IC).

Conclusion

The majority of patients with CCUD-related incontinence experienced improved continence with Coaptite injections. These results support Coaptite as a minimally invasive treatment option for CCUD-related incontinence.

Zitieren

APA

Ku, J., Doshi, C., Basin, M., Dadabhoy, A., Peña, A., Xia, L., Ginsberg, D., Djaladat, H., & Daneshmand, S. (2026). Treatment of Stomal Incontinence with Coaptite Injections in Continent Cutaneous Urinary Diversions. Journal of Endourology. https://doi.org/10.1177/08927790261508366

Vancouver

Ku J, Doshi C, Basin M, Dadabhoy A, Peña A, Xia L, et al. Treatment of Stomal Incontinence with Coaptite Injections in Continent Cutaneous Urinary Diversions. Journal of Endourology. 2026. doi:10.1177/08927790261508366

BibTeX
@article{Ku2026,
  author = {Ku, Josh and Doshi, Chirag and Basin, Michael and Dadabhoy, Anosh and Peña, Adam and Xia, Leilei and Ginsberg, David and Djaladat, Hooman and Daneshmand, Siamak},
  title = {Treatment of Stomal Incontinence with Coaptite Injections in Continent Cutaneous Urinary Diversions},
  journal = {Journal of Endourology},
  year = {2026},
  doi = {10.1177/08927790261508366}
}
Kostenlos starten →